Exchange transfusions can reverse fulminant hepatic failure due to sickle cell intrahepatic cholestasis

Duggan, Raymond; Patel, Parita; Ladd, Daniel; Patel, Tushar
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS152
Academic Journal
An abstract of the article "Exchange Transfusions can Reverse Fulminant Hepatic Failure Due to Sickle Cell Intrahepatic Cholestasis," by Raymond Duggan, Parita Patel, Daniel Ladd and Tushar Patel is presented.


Related Articles

  • Monitoring of Early Field Hepatic Tolerance to NNRTI-Based Regimens with Multiple Biochemical Parameters in Ivorian HIV-1-Infected Patients: A Pilot Study. Kamenan, Boua Alexis Thierry; Abrogoua, Dando Pascal; Djadji, Ayoman Thierry Lenoir; Monnet, Dagui // Pharmacology & Pharmacy;Jan2012, Vol. 3 Issue 1, p79 

    Background: Multiple biochemical parameters related to cytolysis, cholestasis and/or liver failure, can be used to evaluate liver tolerance to antiretroviral (ARV) drugs. What parameters are most suitable for monitoring early hepatic tolerance in the developing countries? Objective: To evaluate...

  • Uszkodzenie watroby w przebiegu mukowiscydozy. Wiecek, Sabina; Wos, Halina; Grzybowska-Chlebowczyk, Urszula // Contemporary Pediatrics, Gastroenterology, Hepatology & Child Fe;2012, Vol. 14 Issue 4, p162 

    Liver damage observed in the course of cystic fibrosis is a group of complicated processes of fibrogenesis, inflammation, remodeling, apoptosis and cholestasis. The complexity of processes which take place in the liver and bile ducts in the course of this disease is not explained. Changes in the...

  • Pediatric liver transplantation in India: Its time has come. D'Cruz, Ashley L. J. // Journal of Indian Association of Pediatric Surgeons;Jan-Mar2011, Vol. 16 Issue 1, p1 

    The author reflects on the practice of pediatric liver transplantation for end-stage liver disease (ESLD) treatment in India. She says that pediatric liver transplants in India was first performed in 1998 wherein most of the centers use live donor transplants. She adds that in India, 280 ESLD...

  • Modified Culture Conditions Enhance Expression of Differentiated Phenotypic Properties of Normal Rat Cholangiocytes. Salter, Kelli D.; Roman, Richard M.; LaRusso, Nicholas R.; Fitz, J. Gregory; Doctor, R. Brian // Laboratory Investigation (00236837);Nov2000, Vol. 80 Issue 11, p1775 

    Lab Invest 2000, 80:1775-1778

  • Hepatic failure caused by plasma cell infiltration in multiple myeloma. Rahhal, Fadi E.; Schade, Robert R.; Nayak, Asha; Coleman, Teresa A.; Deutsch, Melanie Maria // World Journal of Gastroenterology;4/28/2009, Vol. 15 Issue 16, p2038 

    Although plasma cell infiltration is not rare in autopsy of patients with multiple myeloma (MM), it is very rarely detected in living patients. This is because MM rarely causes significant liver dysfunction that requires further evaluation. A 49-year-old man presented with acute renal failure...

  • PROGNOSTIC FACTORS IN ACUTE AND CHRONIC LIVER DISEASES IN CHILDREN. Pop, Tudor L. // Jurnalul Pediatrului;2015 Supp 3, Vol. 18, p92 

    Liver diseases in children have variable clinical manifestations, from asymptomatic increase of transaminases to fulminant liver failure. The disease evolution could be very severe, even fatal without right treatment on right moment. The level of transaminases is not a very valuable for...

  • Farber's Disease Type IV Presenting With Cholestasis and Neonatal Liver Failure: Report of Two Cases. WILLIS, ASHA; VANHUSE, CHERIE; NEWTON, KIMBERLY P.; WASSERSTEIN, MELISSA; MOROTTI, RAFFAELLA A. // Pediatric & Developmental Pathology;Jul/Aug2008, Vol. 11 Issue 4, p305 

    We report 2 siblings diagnosed with Farber's disease type IV. Type IV is a subtype of Farber's disease that presents in the neonatal period and usually initially lacks the triad of symptoms, including painful and deformed joints, subcutaneous nodules, and hoarse cry, classically seen in the...

  • Silymarin as a New Hepatoprotective Agent in Experimental Cholestasis: New Possibilities for an Ancient Medication. Crocenzi, Fernando A.; Roma, Marcelo G. // Current Medicinal Chemistry;2006, Vol. 13 Issue 9, p1055 

    Silymarin is a purified extract from milk thistle (Silybum marianun (L.) Gaertn), composed of a mixture of four isomeric flavonolignans: silibinin (its main, active component), isosilibinin, silydianin and silychristin. This extract has been empirically used as a remedy for almost 2000 years,...

  • Erythropoietic protoporphyria and early onset of cholestasis. Khalili, Manijeh; Farahmand, Fatemeh; Hirbod-Mobarakeh, Armin; Yousefi, Azizollah; Sotoudeh, Soheila; Monajemzadeh, Maryam; Razaghian, Anahita; Rezaei, Nima // Turkish Journal of Pediatrics;Nov/Dec2012, Vol. 54 Issue 6, p645 

    Erythropoietic protoporphyria (EPP) is an inherited defect of mitochondrial ferrochelatase. This defect results in accumulation of protoporphyrin in erythrocytes, plasma, liver, and skin, which causes severe photosensitivity. Liver disease can occur in 1-4% of the patients with EPP, usually...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics